BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 1703371)

  • 1. A bluetongue serogroup-reactive epitope in the amino terminal half of the major core protein VP7 is accessible on the surface of bluetongue virus particles.
    Eaton BT; Gould AR; Hyatt AD; Coupar BE; Martyn JC; White JR
    Virology; 1991 Feb; 180(2):687-96. PubMed ID: 1703371
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Topography and immunogenicity of bluetongue virus VP7 epitopes.
    Wang LF; Hyatt AD; Whiteley PL; Andrew M; Li JK; Eaton BT
    Arch Virol; 1996; 141(1):111-23. PubMed ID: 8629938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RGD tripeptide of bluetongue virus VP7 protein is responsible for core attachment to Culicoides cells.
    Tan BH; Nason E; Staeuber N; Jiang W; Monastryrskaya K; Roy P
    J Virol; 2001 Apr; 75(8):3937-47. PubMed ID: 11264382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fine mapping of a surface-accessible, immunodominant site on the bluetongue virus major core protein VP7.
    Wang LF; Scanlon DB; Kattenbelt JA; Mecham JO; Eaton BT
    Virology; 1994 Nov; 204(2):811-4. PubMed ID: 7941351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isolation of a Bluetongue virus group-specific monoclonal antibody and application to a diagnostic competitive ELISA.
    Xu QY; Sun EC; Yang T; Feng YF; Geng HW; Wei T; Li JP; Sun L; Sun J; Xi N; Zhang Q; Wang HX; Liu EZ; Bu ZG; Wu DL
    Appl Microbiol Biotechnol; 2015 Jan; 99(2):729-39. PubMed ID: 25038929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Presentation of hepatitis B virus preS2 epitope on bluetongue virus core-like particles.
    Belyaev AS; Roy P
    Virology; 1992 Oct; 190(2):840-4. PubMed ID: 1381538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Major core protein VP7 of Australian bluetongue virus serotype 15: sequence and antigenicity divergence from other BTV serotypes.
    Wang LF; Kattenbelt JA; Gould AR; Pritchard LI; Crameri GS; Eaton BT
    J Gen Virol; 1994 Sep; 75 ( Pt 9)():2421-5. PubMed ID: 8077943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression and characterization of bluetongue virus serotype 21 VP7 antigen: C-terminal truncated protein has significantly reduced antigenicity.
    Hosamani M; Shimizu S; Hirota J; Kokuho T; Kubota T; Watanabe S; Ohta M; Muneta Y; Inumaru S
    J Vet Med Sci; 2011 May; 73(5):609-13. PubMed ID: 21187684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nucleotide sequence analysis of VP7 gene of Indian isolates of bluetongue virus vis-à-vis other serotypes from different parts of the world.
    Kovi RC; Dahiya S; Prasad G; Minakshi
    DNA Seq; 2006 Jun; 17(3):187-98. PubMed ID: 17286046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prokaryotic expression of truncated VP7 of bluetongue virus (BTV) and reactivity of the purified recombinant protein with all BTV type-specific sera.
    Pathak KB; Biswas SK; Tembhurne PA; Hosamani M; Bhanuprakash V; Prasad G; Singh RK; Rasool TJ; Mondal B
    J Virol Methods; 2008 Sep; 152(1-2):6-12. PubMed ID: 18611412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ultrastructural distribution of the major capsid proteins within bluetongue virus and infected cells.
    Hyatt AD; Eaton BT
    J Gen Virol; 1988 Apr; 69 ( Pt 4)():805-15. PubMed ID: 2833567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serogroup-reactive and type-specific detection of bluetongue virus antibodies using chicken scFvs in inhibition ELISAs.
    Fehrsen J; van Wyngaardt W; Mashau C; Potgieter AC; Chaudhary VK; Gupta A; Jordaan FA; du Plessis DH
    J Virol Methods; 2005 Oct; 129(1):31-9. PubMed ID: 15946749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bluetongue virus: surface exposure of VP7.
    Lewis SA; Grubman MJ
    Virus Res; 1990 Apr; 16(1):17-26. PubMed ID: 1693461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High level expression of the major core protein VP7 and the non-structural protein NS3 of bluetongue virus in yeast: use of expressed VP7 as a diagnostic, group-reactive antigen in a blocking ELISA.
    Martyn JC; Gould AR; Eaton BT
    Virus Res; 1991 Mar; 18(2-3):165-78. PubMed ID: 1645903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular cloning and comparative sequence analyses of bluetongue virus S1 segments by selective synthesis of specific full-length DNA copies of dsRNA genes.
    Kowalik TF; Yang YY; Li JK
    Virology; 1990 Aug; 177(2):820-3. PubMed ID: 2164738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification and localization of a serotypic neutralization determinant on the VP2 protein of bluetongue virus 13.
    Hwang GY; Li JK
    Virology; 1993 Aug; 195(2):859-62. PubMed ID: 7687805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterisation of monoclonal antibodies to epizootic hemorrhagic disease virus of deer (EHDV) and bluetongue virus by immunisation of mice with EHDV recombinant VP7 antigen.
    Zhou E; Afshar A
    Res Vet Sci; 1999 Jun; 66(3):247-52. PubMed ID: 10333467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A single point mutation in the VP7 major core protein of bluetongue virus prevents the formation of core-like particles.
    Le Blois H; Roy P
    J Virol; 1993 Jan; 67(1):353-9. PubMed ID: 8380082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A single chain Fv antibody displayed on phage surface recognises conformational group-specific epitope of bluetongue virus.
    Nagesha HS; Wang LF; Shiell B; Beddome G; White JR; Irving RA
    J Virol Methods; 2001 Feb; 91(2):203-7. PubMed ID: 11164502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis of bluetongue virus chimeric VP3 molecules and their interactions with VP7 protein to assemble into virus core-like particles.
    Tanaka S; Mikhailov M; Roy P
    Virology; 1995 Dec; 214(2):593-601. PubMed ID: 8553561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.